Manufacturer record
Mayasha Lifesciences: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Mayasha Lifesciences (Himachal Pradesh) were declared Not of Standard Quality between April 2025 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MDT-4228, RABEPRAZOLE SODIUM TABLETS IP (exp Jun 2027). DTL, Puducherry (state lab) found it not of standard quality: Failed Description, Disintegration and Assay. Listed in the September 2026 alert.
Records by type
5 records linked to Mayasha Lifesciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| RABEPRAZOLE SODIUM TABLETS IP | Batch MDT-4228Mfg Jul 2025 · Exp Jun 2027 | Failed Description, Disintegration and AssayAssay | DTL, PuducherryState lab | Sep 2026 |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets | Batch MDT-4458Mfg Sep 2025 · Exp Aug 2027 | The sample does not conform to the claim with respect to Assay of Aceclofenac.Assay | DTL JaipurState lab | Jan 2026 |
| Deflazacort Tablets (Shedef) | Batch MDT-3876Mfg Mar 2025 · Exp Feb 2027 | Assay of Deflazacort. 3.45mg (57.5%) found as claimed 6 mg)Assay | DTL Baddi H.PState lab | Oct 2025 |
| Acclofenac, Paracetamol & Serratiopeptidase Tablets(ASPAZ) | Batch MDT-4102Mfg May 2025 · Exp Apr 2027 | The sample does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab | Oct 2025 |
| Sulphamethoxazole and Trimethoprim Tablets IP | Batch MT386Mfg Oct 2023 · Exp Sep 2026 | Dissolution of Sulphamethoxazol eDissolution | RDTL ChandigarhCDSCO lab | Apr 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.